Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Odysight.ai Reports Financial Results for the First Half of 2024 and Provides Business Update

In This Article:

Odysight.ai Inc.
Odysight.ai Inc.

OMER, Israel, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Odysight.ai Inc. (OTCQB: ODYS), a leading provider of visual based predictive maintenance (PdM) and condition-based monitoring (CBM) solutions, announced its 2024 first half financial results and operational highlights.

Key highlights

Revenue for the first half of 2024 was approximately $1.4 million; Cash Balancei of approximately $13.5 million as of June 30, 2024
--
Raised $10.3 million in private placement during July to accelerate growth, while targeting Nasdaq uplisting
--
Purchase order received for the Israel Air Force (IAF) Boeing AH-64 Apache attack helicopter prototype
--
Purchase orders received from France-based Safran aircraft engines and from Tel Aviv University on behalf of the Israel Ministry of Defense for a bespoke system based on proprietary visual sensors
--
Purchase order received from an international defense contractor for PdM System, to be installed in upgraded IAF maritime version SH-60 Seahawks
--

Yehu Ofer, Odysight.ai's Chief Executive Officer, said"I am proud of Odysight.ai’s achievements in the first half of 2024, as evidenced by the meaningful purchase orders from the IAF, Israel Ministry of Defense and Safran.”

Einav Brenner, Odysight.ai's Chief Financial Officer, added: "Odysight.ai continues to improve its financial performance, reflected by upward trending aerospace revenue. We successfully completed a private placement of $10.3 million in July, supported by both existing and new shareholders, providing the capital to accelerate our growth.”

Financial highlights for the six months ended June 30, 2024 (Unaudited)

Revenues for the six months ended June 30, 2024 were $1.4 million, compared to $1.0 million for the six months ended June 30, 2023, an increase of approximately 40%. The increase is primarily attributable to a higher unit sale price, a growing number of units sold to a Fortune 500 multinational healthcare corporation, as well as Industry 4.0 related revenues.

Cost of Revenues for the six months ended June 30, 2024 was $1.1 million, compared to $1.3 million for the six months ended June 30, 2023, a decrease of approximately 19%. The decrease is primarily attributable to a reduction in the costs of certain materials and improvements in the production process, partially offset by the costs associated with the increase in the number of units sold.

Gross Profit for the six months ended June 30, 2024 was $0.3 million, compared to gross loss of $0.4 million for the six months ended June 30, 2023. The transition to gross profit is attributable to both revenue growth as well as the decrease in cost of revenues.